Olema Pharmaceuticals Inc.
OLMA | NASDAQ
$9.64
-$0.18 (-1.83%)
At close: Sep 21, 2026, 4:00 PM ET
$9.81
+$0.17 (+1.76%)
Pre-market:
Sep 22, 2026, 5:49 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -204.57M | -185.15M | -162.45M | -149.96M | -142.3M | -128.89M | -129.47M | -122.68M | -109.63M | -99.34M | -96.66M | -96.06M | -97.28M | -110.04M | -104.79M | -100.25M | -95.24M | -78.79M | -71.1M | -59.59M | -49.72M | -35.77M |
Depreciation & Amortization | 451K | 481K | 490K | 419K | 471K | 433K | 393K | 365K | 360K | 691K | 1.03M | 1.04M | 1.37M | 1.35M | 1.33M | 1.31M | 940K | 561K | 163K | 93.92K | 46K | 17K |
Stock-Based Compensation | 21.42M | 13.21M | 17.59M | 19.64M | 21.02M | 22.05M | 22.58M | 20.61M | 19.09M | 13.37M | 8.46M | 8.97M | 4.86M | 4.86M | 4.86M | 4.63M | 8.78M | 8.78M | 11.99M | 7.37M | 3.21M | 3.36M |
Other Working Capital | 5.65M | 13.64M | -1.82M | -534K | 2.64M | -4.91M | 6.65M | 12.31M | 1.95M | -6.73M | -2.91M | -6.83M | -1.34M | 6.57M | 2.67M | -1.51M | -313K | 1.72M | 3.51M | 6.34M | 3.55M | 378K |
Other Non-Cash Items | 11.73M | 5.87M | -5.12M | -5.59M | -6.28M | -6.76M | -7.02M | -7.63M | -5.6M | -619K | 5.21M | 6.91M | 10.68M | 12.3M | 13.51M | 15.03M | 11.03M | 10.33M | 5.42M | 6.51M | 7.01M | 3.02M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.18M | -1.18M | -1.18M | -1.18M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 6.23M | 16.86M | 2.77M | 814K | -73K | -11.66M | 9.16M | 12.79M | 4.68M | 248K | -589K | -4.64M | 166K | 6.98M | 3.02M | -1.68M | -577K | 1.61M | 2.83M | 4.52M | 2.92M | 556K |
Operating Cash Flow | -164.74M | -148.72M | -146.72M | -134.67M | -127.16M | -124.83M | -104.35M | -96.54M | -92.27M | -86.83M | -83.73M | -84.96M | -80.21M | -84.55M | -82.07M | -80.96M | -75.06M | -57.51M | -50.69M | -41.1M | -36.54M | -28.81M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | -6K | -159K | -159K | -159K | -153K | n/a | -173K | -312K | -333K | -363K | -889K | -846K | -1.19M | -1.58M | -927K | -821K | -467K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 459K | 459K | 459K | 459K |
Purchase of Investments | -443.18M | -427.81M | -500.72M | -436.6M | -412.42M | -461.72M | -394.96M | -290.64M | -339.12M | -307.34M | -255.63M | -215.2M | -137.7M | -114.88M | -213.66M | -189.12M | -302.81M | -329.96M | -486.97M | -467.01M | -334.87M | -280.16M |
Sales Maturities Of Investments | 343.86M | 321.66M | 344.96M | 328.6M | 333.07M | 343.26M | 301.59M | 280.79M | 257.89M | 245.1M | 250.76M | 257.76M | 226.01M | 218.51M | 305.5M | 271.16M | 351.85M | 360.85M | 213.1M | 186.45M | 67M | 1M |
Other Investing Acitivies | -221K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14K | 14K | 14K | 14K | n/a | n/a | n/a | n/a | n/a | n/a | -459K | -459K | -459K | -459K |
Investing Cash Flow | -99.54M | -106.15M | -155.76M | -108M | -79.35M | -118.47M | -93.53M | -10.02M | -81.37M | -62.38M | -4.85M | 42.4M | 88M | 103.3M | 91.48M | 81.14M | 48.2M | 29.71M | -275.44M | -281.49M | -268.7M | -279.63M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 88K | 88K | 88K |
Common Stock Repurchased | 4.65M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.29M | -2.29M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.41M | -7.91M | -3.5M | -2.7M | -2.7M | 1.52M | 2.44M | 2.19M | 3.06M | 2.34M | 1.42M | 869K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -88K | n/a | n/a |
Financial Cash Flow | 260.4M | 256.78M | 211.3M | 242.05M | 242.1M | 260.22M | 268.82M | 25.04M | 155.58M | 142.02M | 133.42M | 133.17M | 2.64M | 663K | 476K | 1.02M | 972K | 1.42M | 1.39M | 220.36M | 305.18M | 328.42M |
Net Cash Flow | -3.87M | 1.91M | -91.18M | -628K | 35.58M | 16.92M | 70.94M | -81.52M | -18.07M | -7.2M | 44.84M | 90.6M | 10.43M | 19.41M | 9.89M | 1.21M | -25.9M | -26.37M | -324.74M | -102.23M | 50.42M | 70.45M |
Free Cash Flow | -164.74M | -148.72M | -146.72M | -134.67M | -127.16M | -124.84M | -104.51M | -96.7M | -92.43M | -86.99M | -83.73M | -85.14M | -80.52M | -84.89M | -82.43M | -81.85M | -75.91M | -58.69M | -52.27M | -42.03M | -37.36M | -29.28M |
Adj. Free Cash Flow | -186.16M | -161.93M | -164.3M | -154.32M | -148.18M | -146.89M | -127.09M | -117.31M | -111.52M | -100.35M | -92.18M | -94.1M | -85.38M | -89.75M | -87.29M | -86.47M | -84.69M | -67.48M | -64.26M | -49.39M | -40.57M | -32.64M |
Maintenance CapEx | n/a | n/a | n/a | n/a | n/a | -6K | -94K | -94K | -94K | -88K | n/a | -97K | -236K | -257K | -287K | -263K | -174K | -184K | -163K | -93.92K | -46K | -17K |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | n/a | -65K | -65K | -65K | -65K | n/a | -76K | -76K | -76K | -76K | -626K | -672K | -1M | -1.41M | -833.08K | -775K | -450K |
Owner Earnings | -164.74M | -148.72M | -146.72M | -134.67M | -127.16M | -124.84M | -104.45M | -96.64M | -92.37M | -86.92M | -83.73M | -85.06M | -80.45M | -84.81M | -82.35M | -81.22M | -75.24M | -57.69M | -50.85M | -41.19M | -36.58M | -28.83M |
Add to Watchlist
Select watchlists to add or remove OLMA